Fibrinogen Depletion Coagulopathy Predicts Major Bleeding After Thrombolysis for Ischemic Stroke: A Multicenter Study
Authors:
- Michele RomoliMRMichele Romoli
- Laura VandelliLVLaura Vandelli
- Guido BigliardiGBGuido Bigliardi
- Marcello NaccaratoMNMarcello Naccarato
- Maurizio BalestrinoMBMaurizio Balestrino
- Fabrizio GiammelloFGFabrizio Giammello
- Maria Luisa Dell’aCquaMDMaria Luisa Dell’aCqua
- Stefano ForlivesiSFStefano Forlivesi
- Maurizio MelisMMMaurizio Melis
- 1 December 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (12) , 3671-3678
Abstract
Background: Symptomatic intracerebral hemorrhage (sICH) and major bleeding can be fatal complications of intravenous thrombolysis (IVT) for acute ischemic stroke. We investigated the impact of early fibrinogen depletion after IVT on major bleeding events. Methods: This multicenter observational prospective cohort study enrolled 1678 consecutive patients receiving IVT for acute ischemic stroke at 6 Italian centers, undergoing fibrinogen concentration assessment at baseline, 2 hours and 6 hours after IVT. Fibrinogen depletion was defined as a reduction below 200 mg/dL after 2 hours from IVT, or as a reduction below 50% of baseline fibrinogen levels after 2 hours from IVT. Main outcomes were (1) sICH (National Institute of Neurological Disorders and Stroke criteria) and (2) major bleeding defined as fatal bleeding, decrease in the hemoglobin level>2 g/dL/>1 unit transfusion, or bleeding at critical site. Additional outcomes were (1) any ICH, (2) any bleeding, (3) fatal ICH, and (4) sICH according to ECASSII definition. Good functional recovery was defined as modified Rankin Scale score 0 to 2 at 3 months. Results: Overall, 1678 patients were included (mean age 72 years, 46% female). sICH (n=116) and major bleeding (n=297) were associated with lower rate of good functional recovery ( P P =0.012) was attributable to the higher risk of major bleeding/sICH. Conclusions: Fibrinogen depletion significantly increases the risk of sICH and major bleeding after IVT for acute ischemic stroke. Fibrinogen depletion represents an independent risk factor for bleeding, and routine assessment could be considered to stratify the risk of ICH. Trials on early fibrinogen repletion are needed to investigate mitigation of bleeding risk.Keywords
This publication has 20 references indexed in Scilit:
- Fibrinogen Decrease after Intravenous Thrombolysis in Ischemic Stroke Patients Is a Risk Factor for Intracerebral HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2015
- Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysisNeurology, 2013
- Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen ActivatorStroke, 2012
- Intravenous Thrombolysis for Acute Ischaemic Stroke: Effective Blood Pressure Control MattersInternational Journal of Stroke, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic StrokeStroke, 2005
- Early Fibrinogen Degradation Coagulopathy Is Predictive of Parenchymal Hematomas in Cerebral rt-PA ThrombolysisStroke, 2004
- Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic StrokeStroke, 1997